tykhr
sign in
free sign up
Actuate Therapeutics, Inc. Common stock
Biotechnology
Healthcare
ACTU
19.65 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.19
52 week high
11.90
high
7.25
52 week low
0.00
low
6.85
growth
-5.88 %
previous Close
7.09
P/E ratio
market cap
170 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-5.95 M
5.82 %
eps
0.00 %
6.25 %
eps surprise
3.23 %
net profit margin
-594940500.00 %
0.00 %
operating incoming
-5.97 M
6.23 %
net change in cash
2.60 M
154.78 %
cash on hand
6.49 M
66.93 %
cost of revenue
0.00 %
top